Biosensors Market Forecast to Hit USD 61.02 Billion by 2032 Amid Surge in Chronic Disease Prevalence | CAGR of 9.5%

The global Biosensors Market [https://www.coherentmarketinsights.com/market-insight/biosensors-market-1647] is estimated to be valued at USD 32.31 Bn in 2025 and is expected to reach USD 61.02 Bn by 2032, exhibiting a compound annual growth rate (CAGR) of 9.5% from 2025 to 2032. The biosensors market is projected to experience robust growth over the forecast period, fueled by rising demand for fast and accurate diagnostic devices and the increasing prevalence of chronic diseases such as diabetes, cardiovascular disorders, and cancer. Greater health awareness and the growing adoption of wearable healthcare technologies are boosting the use of biosensors in both clinical and non-clinical settings. Additionally, advancements in microfluidics and nanotechnology are enhancing the portability and sensitivity of biosensor devices, further supporting market expansion.

Request a Sample Copy of this Report at: https://www.coherentmarketinsights.com/insight/request-sample/1647

Global Biosensors Market Key Takeaways

According to Coherent Market Insights (CMI), the global biosensors market size is expected to reach USD 32.31 Bn in 2025 and grow at a CAGR of 9.5% during the forecast period, totalling USD 61.02 Bn by 2032.

By technology, electrochemical segment is slated to account for more than two-fifths of the global biosensors market share in 2025.

Hospitals are the leading end users for biosensors, capturing a market share of 30.8% in 2025.

Medical testing remains the most lucrative application for biosensors, accounting for a market revenue share of over 2/5 in 2025.

North America, with an estimated share of 44.9% in 2025, is set to maintain its dominance in the global biosensors market.

Asia Pacific is poised to emerge as a hotbed for biosensor companies during the assessment period.

Rising Incidence of Chronic Diseases Fueling Market Growth

Coherent Market Insights' latest biosensors market analysis outlines key factors fueling industry growth. Increasing prevalence of chronic diseases and growing demand for early diagnosis are among the primary growth drivers.

The global burden of chronic conditions like diabetes, cancer, and cardiovascular diseases is increasing significantly. This, in turn, is fueling demand for diagnostic biosensors for early detection and continuous health monitoring.

Biosensors provide accurate results at a low cost and enable timely diagnosis of various health conditions. They enable medical professionals to provide better treatment options and ensure better health outcomes for their patients.

For instance, glucose biosensors are essential for early detection and continuous monitoring of diabetes. They enable better disease management and patient outcomes. Thus, rising number of people with conditions like diabetes will directly impact biosensor sales in the coming years.

High Manufacturing Costs Limiting Biosensors Market Growth

The future biosensors market outlook looks promising due to expanding applications in healthcare and food sectors. However, high biosensor manufacturing costs remain a significant barrier to widespread adoption.

Biosensors often rely on expensive materials like nanomaterials, enzymes, and bioreceptors. Similarly, advanced fabrication techniques and stringent quality control measures add to overall production expenses. These factors can hinder large-scale commercialization, potentially slowing the market's growth trajectory.

Purchase Now Up to 25% Discount on This Premium Report @ https://www.coherentmarketinsights.com/insight/buy-now/1647

Expanding Use in Food and Environmental Monitoring Creating Opportunities

Rising concerns over food safety, bioterrorism, and environmental pollution are driving demand for advanced monitoring solutions. As a result, the adoption of biosensors for contamination detection and quality control is expected to increase significantly. This trend will likely open lucrative growth opportunities for biosensor manufacturers during the forecast period.

Impact of AI on the Biosensors Market

Just like in other industries, artificial intelligence (AI) is revolutionizing the biosensors market. It significantly enhances accuracy, efficiency, and real-time capabilities of diagnostic systems.

AI-powered algorithms enable advanced data analysis, pattern recognition, and predictive insights from biosensor outputs. This often leads to faster and more precise health monitoring and disease detection.

Adoption of AI is driving innovations in wearable biosensors, point-of-care diagnostics, and personalized medicine. By doing so, it is expanding the application scope of biosensors across healthcare, environmental monitoring, and biotechnology sectors.

Emerging Biosensors Market Trends

Growing demand for point-of-care testing (POCT) is a key trend in the biosensors market. There is a growing shift toward decentralized healthcare and home diagnostics. This is fueling adoption of portable biosensors that deliver rapid results at the point of care.

Rising interest in personalized medicine is expected to boost growth of the biosensors market during the forecast period. This is because biosensors play a crucial role in enabling tailored diagnostics and real-time treatment monitoring.

There is a shift toward wearable biosensors for continuous, real-time health monitoring. These devices are gaining wider popularity for tracking vital signs as well as managing chronic conditions like diabetes.

Integration with wearable devices and IoT is shaping the future of the biosensors market. Growing use of fitness trackers and health monitoring wearables, coupled with IoT connectivity, is enhancing real-time health tracking and enabling remote patient monitoring in telemedicine.

Continuous innovations in nanotechnology, microfluidics, and materials are enhancing sensitivity, portability, and cost-efficiency of biosensor devices. These advancements are expanding applications across various sectors, including healthcare, environmental monitoring, and consumer electronics.

Get Customization on this Report: https://www.coherentmarketinsights.com/insight/request-customization/1647

Analyst's View

"The global biosensors industry is set to experience strong growth, driven by rising prevalence of chronic and infectious diseases, growing need for advanced diagnostic and monitoring tools, expanding applications in food safety and environmental testing, and rapid technological advancements in biosensor technology," said Komal Dighe, a senior analyst at CMI.

Current Events and Their Impact on the Biosensors Market

Event

Description and Impact

Surge in Wearable Health Tech (Apple, Samsung, Abbott expansions)

* Description: Major tech and med-tech companies have launched advanced wearable biosensors capable of real-time glucose, hydration, and cardiac monitoring.

* Impact: This drives consumer-grade biosensor demand as well as pushes for miniaturized, multi-analyte sensors in consumer health.

AI-powered Lab-on-a-Chip Integration

* Description: New biosensors now integrate AI to perform real-time analysis of pathogens and biomarkers on a single chip.

* Impact: These innovations open new markets in emergency diagnostics, personalized treatment, and field hospitals.

Global Rise in Infectious Disease Monitoring (Monkeypox, Avian Flu outbreaks)

* Description: Governments are investing in portable biosensors for early detection in airports, military, and rural areas.

* Impact: This will boost demand for fast, field-deployable, low-cost biosensor systems with IoT connectivity.

Competitor Insights

Key companies in the global biosensors market report:

- Bio-Rad Laboratories Inc.

- Abbott Laboratories

- Medtronic

- Pinnacle Technologies Inc.

- DuPont Biosensor Materials

- Biosensors International Group, Ltd.

- Ercon, Inc.

- LifeScan, Inc.

- Johnson & Johnson

- QTL Biodetection LLC

- Molecular Devices Corp.

- Koninklijke Philips N.V.

- Molex LLC

- Nova Biomedical

- TDK Corp.

- Siemens Healthcare

- Zimmer & Peacock AS

Key Developments

In April 2025, Medtronic plc received U.S. FDA approval for the Simplera Sync sensor for use with the MiniMed 780G system. It is the company's latest addition to its CGM portfolio.

In August 2024, Dexcom launched its first OTC continuous glucose biosensor, Stelo, in the United States. The new device is intended to deliver personalized glucose insights via a wearable sensor and smartphone app to adults with type2 diabetes who do not use insulin.

In June 2024, Abbott launched the Lingo biosensor and Libre Rio CGM system in the United States. This move will help the company to strengthen its position in the consumer biowearables market.

Detailed Segmentation-

* By Technology

* Electrochemical
* Optical
* Peizoelectric
* Thermistore

* By Application

* Medical testing

* Cholesterol
* Blood glucose
* Blood gas analyzer
* Pregnancy testing
* Drug discovery
* Infectious disease

* Food toxicity
* Industrial process
* Environment
* Agricultural testing
* Others

* By End User

* Hospitals
* Home Healthcare Diagnostics
* Research laboratories
* Security and bio-defense
* others

* By Region:

* North America
* Europe
* Asia Pacific
* Latin America
* Middle East
* Africa

About Us:

Coherent Market Insights leads into data and analytics, audience measurement, consumer behaviors, and market trend analysis. From shorter dispatch to in-depth insights, CMI has exceled in offering research, analytics, and consumer-focused shifts for nearly a decade. With cutting-edge syndicated tools and custom-made research services, we empower businesses to move in the direction of growth. We are multifunctional in our work scope and have 450+ seasoned consultants, analysts, and researchers across 26+ industries spread out in 32+ countries.

Media Contact
Company Name: Coherent Market Insights
Contact Person: Mr. Raj Shah
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=biosensors-market-forecast-to-hit-usd-6102-billion-by-2032-amid-surge-in-chronic-disease-prevalence-cagr-of-95]
Phone: 2524771362
Address:533 Airport Boulevard, Suite 400, Burlingame, CA 94010, United States
City: Burlingame
State: California
Country: United States
Website: https://www.coherentmarketinsights.com/market-insight/biosensors-market-1647 [http:// https://www.coherentmarketinsights.com/market-insight/biosensors-market-1647]

Legal Disclaimer: Information contained on this page is provided by an independent third-party content provider. ABNewswire makes no warranties or responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you are affiliated with this article or have any complaints or copyright issues related to this article and would like it to be removed, please contact retract@swscontact.com



This release was published on openPR.